Physician profile
Ehsan Dowlati
NPI 1912360173
$5,385.53
in general payments reported to CMS, 2019-2025
12 companies · $864 in 2025
The $864 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $34.12 · 2023: $3,389 · 2024: $1,099 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,254 · Travel and Lodging: $1,803 · Education: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,253.51 |
| Travel and Lodging | $1,802.91 |
| Education | $294.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,689.57 | 2023-2025 | Neuroform Ez 3, Target, Tritanium |
| Globus Medical, INC. | $576.03 | 2023-2025 | Creo, Excelsius3d Imaging System, Adira |
| Microvention, INC. | $447.30 | 2023 | Stent, Web Aneurysm Embolization System |
| Baxter Healthcare | $367.07 | 2023-2025 | Floseal, Tisseel |
| Penumbra, INC. | $330.64 | 2024-2025 | Penumbra System, Red 72 |
| Medical Device Business Services, INC. | $294.99 | 2024 | |
| Carlsmed, INC. | $215.22 | 2023 | Aprevo |
| Depuy Synthes Sales INC. | $180.50 | 2023-2025 | Embotrap, Cerepak Uniform, Emboguard |
| Imperative Care, INC | $120.70 | 2024 | Zoom 88-T Large Distal Platform |
| Davol INC. | $79.14 | 2023 | Avitene Ultrafoam |
| Medtronic, INC. | $52.87 | 2022-2024 | Pipeline |
| Si-Bone, INC. | $31.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ehsan Dowlati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.